Call Us: 763-333-6990

Research

The Alleamâ„¢ skin cream is designed to trigger a cross-react immune response wherein IgE-primed effector cells inhibit the expression of endogenous proteins associated with metastasizing cells. The cancer patient’s allergic-profile, and component sensitization pattern can be evaluated to provide a skin-cream that intensifies the cross-react mechanism. Furthermore, systemic cross-reactions are intended to shift the bodies resource allocation from metastatic cell formation to antibody and effector cell production (i.e., adaptive immunity).

Michael J Dochniak, Rubber Elongation Factor and Natural Allergy-Oncology, 2016, Open Access 2: 027, BAOJ Cancer Research & Therapy, Wilmington Delaware, USA.